# A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

> **NCT06114745** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 2 (actual)

## Conditions studied

- Alzheimer's Disease (AD)

## Interventions

- **DRUG:** SHR-1707 injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06114745
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-17
- **Primary completion:** 2025-07-08
- **Final completion:** 2025-07-08
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06114745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06114745, "A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06114745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*